Immunobiology and Host Response to HEV
- PMID: 37223861
- DOI: 10.1007/978-981-99-1304-6_7
Immunobiology and Host Response to HEV
Abstract
Hepatitis E virus (HEV) usually causes acute self-limiting hepatitis but sometimes leads to chronic infection in immunocompromised persons. HEV is not directly cytopathic. Immunologically mediated events after HEV infection are believed to play important roles in the pathogenesis and clearance of infection. The anti-HEV antibody responses have been largely clarified since the determination of major antigenic determinant of HEV, which is located in the C-terminal portion of ORF2. This major antigenic determinant also forms the conformational neutralization epitopes. Robust anti-HEV immunoglobulin M (IgM) and IgG responses usually develop 3-4 weeks after infection in experimentally infected nonhuman primates. In humans, potent specific IgM and IgG responses occur in the very early phase of the disease and are critical in eliminating the virus, in concert with the innate and adaptive T-cell immune responses. Testing anti-HEV IgM is valuable in the diagnosis of acute hepatitis E. The long-term persistence and protection of anti-HEV IgG provide the basis for estimating the prevalence of HEV infection and for the development of a hepatitis E vaccine. Although human HEV has four genotypes, all the viral strains are considered to belong to a single serotype. It is becoming increasingly clear that the innate and adaptive T-cell immune responses play critical roles in the clearance of the virus. Potent and multispecific CD4+ and CD8+ T cell responses to the ORF2 protein occur in patients with acute hepatitis E, and weaker HEV-specific CD4+ and CD8+ T cell responses appear to be associated with chronic hepatitis E in immunocompromised individuals.
© 2023. The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
Similar articles
-
Immunobiology and Host Response to HEV.Adv Exp Med Biol. 2016;948:113-141. doi: 10.1007/978-94-024-0942-0_7. Adv Exp Med Biol. 2016. PMID: 27738982 Review.
-
Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques.J Hepatol. 2021 Sep;75(3):557-564. doi: 10.1016/j.jhep.2021.04.036. Epub 2021 May 4. J Hepatol. 2021. PMID: 33961939 Free PMC article.
-
Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.J Hepatol. 2024 Apr;80(4):564-575. doi: 10.1016/j.jhep.2023.12.016. Epub 2023 Dec 26. J Hepatol. 2024. PMID: 38154741
-
Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors.J Clin Virol. 2018 Aug;105:26-30. doi: 10.1016/j.jcv.2018.05.013. Epub 2018 May 29. J Clin Virol. 2018. PMID: 29860111
-
Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.Rev Med Virol. 2012 Sep;22(5):339-49. doi: 10.1002/rmv.1719. Epub 2012 May 30. Rev Med Virol. 2012. PMID: 22645002 Review.
References
-
- Kureljušić B, Aleksić-Kovačević S, Savić B, Prodanović R, Jezdimirović N, Milićević V et al (2021) Morphological and immunophenotypic characteristics of the liver of swine naturally infected with hepatitis E virus. Vet Ital 57(4):287–295 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials